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Abstract MicroRNAs are small non-coding RNAs
endogenously expressed by all tissues during development
and adulthood. They regulate gene expression by control-
ling the stability of targeted messenger RNA. In
cardiovascular tissues microRNAs play a role by modu-
lating essential genes involved in heart and blood vessel
development and homeostasis. The zebrafish (Danio rerio)
system is a recognized vertebrate model system useful to
study cardiovascular biology; recently, it has been used to
investigate microRNA functions during natural and path-
ological states. In this review, we will illustrate the
advantages of the zebrafish model in the study of mi-
croRNAs in heart and vascular cells, providing an update
on recent discoveries using the zebrafish to identify new
microRNAs and their targeted genes in cardiovascular
tissues. Lastly, we will provide evidence that the zebrafish
is an optimal model system to undercover new microRNA
functions in vertebrates and to improve microRNA-based
therapeutic approaches.
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MiRNAs: function and mechanism
MicroRNAs (e.g., miRs or miRNAs) are evolutionary
conserved small non-coding RNAs, usually 21–25 nt long,
that regulate gene expression at a post-transcriptional level.
MiRNAs act by impairing target mRNA expression through
an antisense mechanism. They recognize partial or full
complementary sequences that are present mainly in the 30-
UTR (untranslated region) of mRNAs and thereby inhibit
protein synthesis [1, 2]. Based on their locations in the
genome, microRNAs can be intergenic and so transcribed
individually as single transcriptional units or intragenic
(intronic or exonic) and then transcribed together with the
genes in which they are located. Often, more miRNAs are
located close by in the genome and form clusters; in this
case they are transcribed in a single polycistronic unit that
after cleavage releases single microRNAs [3, 4].
MiRNAs are transcribed by RNA polymerase II as a stem-
loop precursor known as pri-miRNA. In the nucleus it is
cleaved by a ribonuclease III enzyme called Drosha with its
cofactor DiGeorge syndrome critical region 8 (DGCR8) into
60–100-nucleotides hairpins called pre-miRNA that can
leave the nucleus through exportin 5. In the cytoplasm a
second RNase, Dicer, removes the loop that generates a
duplex containing the mature miRNA sequence and a ‘pas-
senger strand’ miRNA sequence (called star). Subsequently,
the miRNA duplex is recognized by the protein complex
Argonaute to form the RNA-induced silencing complex
(RISC). Thus the ‘seed’ region of mature miRNA (nucleo-
tides 2–8) guides RISC on target mRNA(s). MiRNAs post-
transcriptional regulation of gene expression can be achieved
through different mechanisms: (1) degradation of the tar-
geted mRNA and/or (2) translation repression. Recently, a
role for miRNA in translational simulation has also been
proposed [2, 5–7]. While miRNAs commonly repress their
mRNA targets, in rare cases it has been observed that miRNA
stimulation of mRNA translation occurs [8].
MiRNAs have numerous high- and low-affinity targets
and therefore have the potential to modulate multiple
pathways. Often many of these targets can themselves
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control the expression and function of miRNAs generating
regulatory circuits [9–12]. In positive feedback circuits,
miRNAs repress a repressor, leading to activation of tran-
scription factors that activate miRNA expression. The
regulatory loop formed between miR-1, HDAC4, and
MEF2 exemplifies this form of regulation in skeletal
muscle [13]. Here, repression of HDAC4 by miRNA-1
derepresses the activity of the MEF2 transcription factor,
which in turn activates expression of miRNA-1 and other
target genes. On the other hand, miRNAs can also establish
negative feedback circuits by repressing activators of
miRNA/mRNA expression. In a negative regulatory loop,
miRNAs repress transcription factors that are required for
miRNA expression, leading to decreased expression of
miRNAs. The reciprocal regulatory interaction among a
posterior Hox gene, nob-1, and miRNA-57 has been found
to be essential for regulation of posterior cell fate deter-
mination in C. elegans [14]. On one hand, the Hox gene is
required for normal activation of miRNA-57 expression,
and on the other, the Hox gene functions as a direct target
of and is repressed by the miRNA. Given the conservation
of the two genes, a negative feedback loop between Hox
and miRNA genes might be broadly used across species to
regulate cell fate along the anteroposterior axis [14].
In addition, 30-UTRs can contain binding sites for
multiple miRNAs, allowing redundancy and cooperation
between them. Collectively, these mechanisms establish a
complex network of gene regulation that fine-tunes the
biological processes [9, 15].
MiRNAs are widely expressed in almost all vertebrate
tissues, and functional roles for miRNA during develop-
ment have been extensively described [16, 17]. MiRNA
expression has been linked to a wide range of physiologic
processes, including development, differentiation, and cell
proliferation. Therefore, it is likely that miRNAs partici-
pate in nearly every physiological process since miRNA
expression is temporally and spatially regulated.
The role of miRNAs in shaping heart and vascular
networks in vertebrates
The heart is the first organ to form and function during
embryo development, and its continued contraction is
essential for life. Processes that lead to heart development
are very complex, and their alterations can result in con-
genital heart disease; functional abnormalities in the adult
heart result in a variety of disorders, among which are
arrhythmias, cardiomyopathies, heart failure, and sudden
death [18, 19]. In vertebrates, the linear heart tube forms
from the migration of bilateral populations of myocardial
and endocardial cells and their fusion at the midline. Then,
morphogenetic movements lead to the formation of a
looped, multichambered organ [20]. The heart has the
function to pump blood in the vascular system. The vas-
cular system is a highly organized network of arteries,
capillaries, and veins that supplies virtually all body tis-
sues, enabling an efficient exchange of oxygen and
nutrients and removal of waste products. The vascular
system is indispensable for embryonic development and
adult life, and its aberrant alterations are associated with
numerous diseases, including cancer, atherosclerosis, reti-
nopathy, and stroke [21]. The generation of the vascular
system starts with a process called vasculogenesis that give
rises to the primary vascular plexus of the embryo from
which new vessels sprout in a process called angiogenesis
[22]. During this phase, the vascular plexus progressively
expands and remodels into a highly organized and stereo-
typed vascular network. The development and maturation
of the cardiovascular system also require the recruitment of
smooth muscle cells that stabilize vessels and regulate
blood flow [23, 24]. After birth, angiogenesis still con-
tributes to organ growth, but, during adulthood, most blood
vessels remain quiescent until they receive physiopatho-
logical cues that stimulate endothelial cells (ECs)
proliferation.
Cardiovascular formation and function are precisely
controlled by a network of transcription factors closely
intertwined with families of microRNAs that modulate
multiple aspects of cardiovascular development, function,
and dysfunctions [12]. The importance of microRNAs in
the regulation of cardiovascular development and function
has been demonstrated through earlier studies on vertebrate
mutants of Dicer, the enzyme required for microRNA
biogenesis [25–29]. The complete loss of Dicer function
leads to severe developmental defects in both zebrafish and
mouse. To overcome the early lethality, conditional Dicer
mutant mice were created [30]. Cardiac-specific deletion of
Dicer leads to cardiomyopathy, heart failure, and postnatal
lethality [31]. Again, in mammals specific inactivation of
Dicer in endothelial cells shows that endothelial micro-
RNAs are important for postnatal angiogenic responses to a
variety of stimuli, including VEGF, tumors, limb ischemia,
and wound healing [32]. In mouse the loss of Dicer in
vascular smooth muscle cells lead to a dilated, thin-walled
blood vessels that also exhibited impaired contractility
[33]. Zebrafish maternal-zygotic Dicer mutants (that lack
both maternal and zygotic Dicer) display abnormal mor-
phogenesis during gastrulation, brain formation,
somitogenesis, and heart development. However, it has
been shown that the injection of miRNA-430 rescues early
gastrulation defects, enabling the analysis of the loss of
microRNAs in tissues that otherwise would not develop
[28, 34]. Recent studies on zebrafish Dicer mutant embryos
demonstrated excessive endocardial cell formation, sug-
gesting a role for miRNA in cardiac development [35]
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(Fig. 1). These studies indicate that the zebrafish system
can be a valuable tool to investigate microRNA’s function
in vivo, especially for studying cardiovascular develop-
ment and homeostasis where this model presents some
unique features among other vertebrate and mammalian
models [36].
The zebrafish model system to study cardiovascular
miRNA functions
The zebrafish as a model for cardiovascular studies
The zebrafish (Danio rerio) system has emerged in the past
years as an ideal vertebrate model organism to study a wide
variety of biological processes [37–39]. Some of the
advantages of the zebrafish animal model system include
high fecundity, external fertilization, rapid development,
and optical clarity. Last but not least, the zebrafish has low-
cost maintenance compared to other vertebrate model sys-
tems. The importance of zebrafish for cardiovascular
research relies on some unique characteristics such as the
early development of a functional cardiovascular system
(beating heart, aorta, cardinal vein, and blood) that is already
formed by 24 h post-fertilization (hpf) [20, 40]. Since the
zebrafish embryo is relatively small and aquatic, oxygen can
diffuse passively through tissues, and thus embryos can
live more than 3 days without a functional cardiovascular
system [41]. This allows genetic manipulation of cardio-
vascular development for longer than it would be in
mammals, where the absence of a functional cardiovascular
system is fatal at its early stage of development. Until 5 days
post-fertilization (dpf), the embryos are nearly transparent,
allowing in vivo visualization during development (even at
single-cell resolution) of the heart, blood vessels, and other
tissues, without instrumentation or manipulation other than
the use of a stereomicroscope. Furthermore, the generation
of tissue-specific transgenic lines is relatively easy thanks to
the availability of hundreds of fertilized eggs with the
injection of DNA and RNA constructs [42]. Such a method
usually uses a native tissue-specific promoter to drive
expression of a fluorescent reporter protein, such as green
fluorescent protein (GFP). The following transgenic lines
are of great interest for cardiovascular studies: Fli1:GFP
(which expresses GFP in endothelial cells and some neu-
ral crest-derived cells) [43], kdrl:GFP (which expresses
GFP localized to endothelial cells) [44], gata1:dsRED (which
expresses dsRED in erythrocytes) [45], cd41:GFP
(which expresses GFP in thrombocytes) [46], cmlc2:GFP
(which expresses GFP in cardiomyocytes) [47], and
tgnl:Cherry (which expresses cherry in smooth muscle cells)
[48]. Coupled with impressive optical clarity, these trans-
genic lines allow observation of in vivo cellular behavior in a
way impossible in other models. Transparent zebrafish
embryos are also well suitable for in vivo time-lapse imag-
ing. The fast acquisition speed of a spinning disk and two-
photon confocal microscopy reduces the recording time
significantly when millimeter-sized embryos need to be
imaged at high resolution and at short time intervals. Light
sheet fluorescence microscopy could also be very useful in
zebrafish [49, 50]. These attributes, including the possibility
of carrying out gain- and loss-of-function studies have led to
the emergence of the zebrafish as an excellent embryological
model that provides a unique opportunity to uncover novel
insights into the molecular genetics of development and
disease.
More recently, the zebrafish has become an attractive
model to study the effects of genetic variations identified in
Fig. 1 Molecular and
functional consequences of the
loss of Dicer activity in
maternal-zygotic dicer mutants
embryos (MZdicer KO). In
zebrafish mutants lacking dicer
enzymatic activity, pre-
microRNAs are not processed in
mature microRNAs, leading to
several developmental defects.
The lack of miR-430 miRNAs
leads mainly to gastrulation,
brain formation, and
somitogenesis defects. The loss
of other microRNAs affects
embryo morphogenesis and
organogenesis, as well as heart
development and blood
circulation
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patients with cardiovascular defects by candidate gene or
whole-genome-association studies [51, 52]. Moreover,
zebrafish are suitable for forward genetics approaches,
which allow the unbiased identification of novel and
unanticipated cardiovascular genes. Small and large
mutagenesis screens have been conducted in zebrafish and
have led to a wealth of heart and endothelial mutants,
several of which have already been characterized in detail
and positionally cloned [41, 53]. Zebrafish mutants with
various cardiovascular phenotypes that closely correlate
with human disease, such as congenital heart disease,
cardiomyopathies, and arrhythmias, have also been isolated
[54]. The pool of zebrafish mutants for which the causal
gene mutation has been identified is constantly growing.
The human orthologs of several of these zebrafish genes
have been shown to be involved in the pathogenesis of
human cardiovascular diseases (CVD), known to be the
most common cause of worldwide deaths [51, 54]. Car-
diovascular zebrafish models also provide the opportunity
to develop and test novel therapeutic strategies, using
innovative technologies such as high-throughput in vivo
small molecule screens.
The zebrafish as a model for miRNA studies
Zebrafish is a helpful model system to study miRNA
function and characterize miRNA:mRNA target interac-
tions [55–58]. Important information regarding the
conservation of miRNA genes in vertebrates has been
derived from the identification and characterization of
miRNAs in zebrafish. Danio rerio have also proven to be a
particularly valuable system to study miRNA functions in
developmental processes. In the last decade different
analyses have led to the identification of 415 zebrafish
miRNAs, and based on seed sequence identity, it has been
possible to group these into 44 families [59–61]. However,
the exact number of zebrafish miRNAs might be higher,
since genome sequencing and annotation has not been fully
completed. Thus far, most zebrafish miRNAs exhibit tis-
sue-specific patterns of expression [62].
miRNA expression analyses
To understand the function of specific microRNAs, it is
important to determine their spatial and temporal expres-
sion pattern. Several methods have been developed to
evaluate miRNA expression in zebrafish. Due to their rel-
atively small size and optical transparency, zebrafish are
useful for whole-mount in situ hybridization (ISH) analy-
ses. However, compared to gene expression analysis, ISH
detection of miRNAs can sometimes be challenging
because of the microRNA’s relatively small size (usually
21–25 nt), which then lowers the probe signals. Therefore,
non-radioactive-labeled synthetic RNA oligonucleotide
probes, such as 2-O-methyl RNA oligonucleotides, and
locked nucleic acids (LNA) are currently used since they
can overcome this problem, allowing an overall enhancing
of the probe signal [6, 63]. To distinguish between genes
that encode the same mature miRNA sequence, Postleth-
wait and collaborators [64] developed the use of
digoxigenin-labeled riboprobes designed to bind to miRNA
primary transcripts, allowing the observation of miRNA
expression for both intergenic and intronic miRNAs.
Alternatively to ISH, zebrafish microRNA expression pat-
terns have also been investigated by qPCR, microarray,
RNA-seq, and Northern blot analyses at different devel-
opmental stages and in different tissues [55, 59, 65]. As a
result, a set of specific miRNAs displays cardiovascular-
specific expression patterns, suggesting functional roles in
differentiation or homeostasis of these miRNAs during
development in zebrafish.
Control of microRNA expression
Modulation of miRNA expression can be achieved in
several ways in zebrafish. For gain-of-function studies, the
most widely used technique is the injection in one-cell eggs
of double-stranded miRNA mimics to promote single
miRNA overexpression [66, 67]. It must be taken into
consideration that in this way the specific miRNA is
overexpressed not only in the tissues where it is endoge-
nously expressed, but also in the entire embryo. However,
it could be useful to mimic situations in which a microRNA
is spatio-temporally deregulated. To analyze the role of
microRNA gain of function in a specific tissue, DNA
constructs in which a tissue-specific promoter controls pri-
miRNA expression can be used. More sophisticated genetic
techniques based on the CreERT2/loxP system have been
described in zebrafish, and they can also provide temporal
and tissue-specific miRNA expression in zebrafish embryos
[68, 69]. These strategies will allow the study of miRNA
functions not only in the developing embryos, but also in
adult animals and their exclusive tissues of interest.
Inhibition of specific miRNAs can be obtained by the
injection of miRNA modulators, among which are cho-
lesterol-modified antagomirs, modifications such as 20
O-methoxyethyl phosphorothioate or 20 fluoro substitutions,
as well as oligonucleotides stabilized by LNA phosphoro-
thioate chemistries. Although these techniques, especially
antagomirs, are successfully used in mammals, they do not
work quite efficiently in zebrafish embryos, mainly because
their chemistry is not compatible with the lipid-enriched
zebrafish yolk sac [70]. Conversely, antisense morpholino
phosphorodiamidate oligonucleotides (MOs) have been
extensively used to knock down gene functions in zebrafish
embryos and larvae [71–73]. To inhibit specific miRNAs,
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MOs must be designed to block the processing of pre-
miRNA or the activity of the mature miRNA [74, 75]. A
recent alternative approach to inhibit miRNA function
in vivo is to use miRNA ‘sponges’ or ‘decoys.’ They
contain several miRNA-binding sites, and, when present in
a cell as RNA, act as competitive inhibitors for miRNA
binding [76, 77]. Placing a miRNA sponge in the 30-UTR
of a reporter gene (dGFP in most cases), it is also possible
to obtain information about the miRNA expression pattern
and to down-modulate it at the same time. Interestingly,
miRNA sponges have also been used to generate miRNA
tissue-specific and stable knockdown [78, 79]. The use of
sponges can be useful to overcome morpholinos off-target
effects and to obtain a stable or prolonged knockdown not
achievable with morpholinos because of their relative short
half-life. Recently, targeted gene inactivation via zinc fin-
ger nucleases (ZFN) has been established for zebrafish
genome [80, 81]. This technique, allowing the introduction
of targeted lesions in the zebrafish genome, could, in
principle, be used to selective targeted pre-miRNA
sequences. The TALEN technology could also be used to
induce somatic mutagenesis in zebrafish microRNA genes
[82, 83].
Finally, compared to mammalian models the zebrafish
system also has the unique feature of being able to perform
‘‘transient’’ knockdown (by morpholino) and rescuing (by
mimics) of microRNAs in whole embryos. Such genetic
techniques cannot be achieved so easily in rodents in a
short period of time [36].
Target prediction and validation tools
Several open-access bioinformatic databases have been
developed to facilitate the analysis of miRNAs and their
target prediction. However, prediction of miRNA–mRNA
interactions still remains challenging, owing to the short
length of miRNAs, requirement of only partial homology
for binding, redundancy among members of an miRNA
family, and the existence of multiple putative miRNA
recognition sites [84, 85]. The majority of the computa-
tional target prediction programs are based on several
features, such as complementarity between the 50-seed of
the miRNA and the 30-UTR of the target mRNA, thermo-
dynamic stability of the miRNA-mRNA duplex, conser-
vation among species, and the presence of several miRNA
target sites. However, in zebrafish different in silico target
prediction programs exist. They use prediction algorithms
based on mammalian counterparts [86]. Such prediction
programs must be used carefully in zebrafish studies since
(1) the zebrafish genome is not fully sequenced, (2) only a
limited number of miRNA targets have been experimen-
tally validated, and (3) there is low conservation among
species regarding mature microRNA sequences as well as
the target prediction. Experimental high-throughput studies
(such as poly(A)-site mapping followed by RNA-Seq) are
needed to allow for generation of zebrafish precise pre-
diction algorithms [27]. To validate predicted miRNA–
mRNA interactions, several in vitro experimental approa-
ches can be used, such as biochemical methods (luciferase
assays, qRT-PCR, Western blot, RNA seq), ‘‘omics’’
approaches (SILAC, LAMP), and RISCome analysis
(quantification of mRNAs in the RNA-induced sequencing
complex; RISC RNA sequencing, RIP-chip) [87]. The
zebrafish system allows the validation of target mRNA
in vivo. Novel techniques have been recently implemented
in the zebrafish model such as fluorescent miRNA sensor
and MO target protector. In the first case, validation of the
target prediction is tested using a reporter assay based on
monitoring GFP/cherry fluorescence in zebrafish embryos
microinjected with mRNA encoding the fluorescent
reporter fused to the 30-UTR of the target gene in the
presence or absence of a specific miRNA duplex [67, 88].
In this assay, a decrease in fluorescence in the presence of
miRNA duplex indicated miRNA-mediated repression and
then the confirmation of the target in vivo. In the second
case, MOs are designed to be complementary to specific
miRNA-binding sites in target mRNAs. In this way, MOs
have been shown to efficiently protect the target mRNA
from translational inhibition or degradation [89, 90]. To
study the regulation of a particular target, it is important to
first establish that the 30-UTR is regulated by a particular
miRNA. miRNAs may speed degradation or slow transla-
tion of their targets, but repression caused by either
mechanism can be assessed by measuring the protein out-
put of a reporter. The efficiency of ‘‘target protectors’’ to
block the interaction of miRNAs with a particular binding
site in a target mRNA can also be investigated by co-
injections with reporter mRNAs containing a GFP/cherry
coding sequence and a 30-UTR region with the miRNA-
binding site [65, 91]. Subsequently, a tested target protector
can be used to study whether protection of a specific target
mRNA from silencing has any biological effect also in a
tissue-specific manner (by generation of a cell autonomous
miRNA sensor) [65, 67].
MicroRNAs involved in heart and vascular
development and homeostasis in zebrafish
The functions of individual miRNAs in normal and path-
ological angiogenesis are just starting to be unveiled.
Single miRNAs may regulate cardiovascular functions
either cell-autonomously or non-cell autonomously. Recent
progress toward understanding the functions of specific
miRNAs in cardiovascular development and homeostasis
has been done. Here, we described those miRNAs whose
The admiR-able advances in cardiovascular biology through the zebrafish model system
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functions in the zebrafish cardiovascular system have been
addressed (Table 1).
Heart-specific miRNAs
Heart formation and function are precisely controlled by
networks of transcription factors closely intertwined with
families of miRNAs that modulate multiple aspects of
cardiac development, function, and dysfunctions. Here, we
report some miRNAs whose function has also been char-
acterized through the use of zebrafish (Fig. 2).
The miRNA 23
Defects in cardiac valves are the most common subtype of
cardiovascular malformations, and in adults they remain a
major cause of morbidity and mortality [92]. Increasing the
molecular understanding of processes that control heart
valve development and remodeling could be useful to
improve or develop new therapeutic approaches. In this
sense it could be relevant that the discovery of one gene
involved in heart valve development is miRNA-23 [35]. It
has been showed that zebrafish MZDicer mutants have
endocardial defects, including excessive endocardial
cushion formation, and Lagendijk et al. demonstrated that
they are caused by the loss of miRNA-23 activity. In this
process, miRNA-23 acts to downregulate has2 (hyaluronic
acid synthase 2), an extracellular remodeling enzyme
known to be required for endocardial cushion and valve
formation [93] and whose upregulation in MZDicer
mutants authors showed to be responsible for the observed
valve defects. Furthermore, they demonstrated that in mouse
endothelial cells, miRNA-23 is able to inhibit a transform-
ing growth factor-beta (TGF-b)-induced endothelial-to-
mesenchymal transition (EMT), a process that normally
occurs during heart valve development. So the authors
proposed a model in which miRNA-23, has2, and its
product hyaluronic acid (HA) create a feedback regulatory
loop that could respond to the AVC signal, such as TGF-b,
and restrict endocardial cushion formation to the AVC
region. Data shown in zebrafish and mouse endothelial
cells suggest a conserved role of miRNA-23 whose func-
tion in mammalian valve development is still unknown but
which could be interesting to investigate.
The miRNA 138
A precise regulation in time and space of gene expression
and protein activity is fundamental for a proper develop-
ment of a chambered heart. Morton et al. [70] demonstrated
that miRNA-138 is necessary to establish appropriate
chamber-specific gene expression patterns during embry-
onic development. This microRNA is expressed in specific
domains of the heart, and its downregulation leads to
ectopic expression in the ventricle of genes normally
expressed in the atrioventricular valve region (AVC). As a
consequence, ventricular cardiomyocyte morphology and
cardiac function are affected. The microRNA function is to
partially repress aldh1a2 in the ventricle, a gene that
encodes retinoic acid (RA) dehydrogenase, an enzyme
involved in RA synthesis. miRNA-138 also mediates
ventricular repression of cspg2, a gene positively regulated
by RA signaling. This study demonstrates that, targeting
multiple members of a common pathway, miRNA-138
establishes discrete temporal and spatial domains of gene
expression during cardiac morphogenesis, which is neces-
sary for the correct development of the heart. This
microRNA is highly conserved across species as well as
Fig. 2 Schematic
representation of zebrafish heart
at 72 hpf, which shows the
bulbus arteriosus (BuA), atrium
(A), ventricle (V), and the atrio-
ventricular valve (AVC, dashed
circle). Green indicates the
pericardium, purple the
myocardium, pink the
endocardium, and blue smooth
muscle cells. Each of these
tissues expresses specific
microRNAs that are shown
along with their targets.
Inhibition of the specific target
expression allows for a specific
functional role of the different
microRNAs in cardiogenesis
(see text for details)
The admiR-able advances in cardiovascular biology through the zebrafish model system
123
transcriptional networks that control heart patterning [94],
and so it could be interesting to analyze miRNA-138
functions in mammalian heart in which RA signaling plays
a key role during development [95].
The miRNA 143/145 cluster
In mammals, miRNA-143 and miRNA-145 are two smooth
muscle cell-specific microRNAs playing a role in vascular
SMC phenotypic switch [96–99]. These microRNAs are
expressed in early cardiac progenitors and throughout the
embryonic heart before becoming restricted to vascular and
visceral smooth muscle cells. Despite being expressed at
high levels in the developing heart, no cardiac function for
the miRNA-143/145 cluster in developing mammalian
heart has been found [98, 99]. Although the downregula-
tion of miRNA-145 affects cardiac development [66], its
role in this organ has not yet been fully investigated in
zebrafish. On the contrary, a role of miRNA-143 in car-
diogenesis in zebrafish has been reported. In particular, it
has been demonstrated that miRNA-143 is involved in the
conversion of mechanical stimuli into biological output
(mechano-transduction pathway) in the heart [100], a
process that is important during the later phases of cardiac
development when hemodynamic forces play an essential
role in the morphogenesis and adaptation of the heart to the
circulatory demands. The authors showed that miRNA-143
expression in the myocardium and endocardium of outflow
tract and ventricle is heartbeat-dependent. Blocking the
heartbeat with the injection of tnnt2 (cardiac troponin T2)
morpholino or with BDM (2,3-butanedione monoxime)
treatment, miRNA-143 cardiac expression is reduced or
abolished. They showed that the loss of miRNA-143 leads
to pericardial edema and heart defects: the atrium of
miRNA-143 morphants is swollen, and the ventricle
doesn’t inflate, maintaining a tube-like structure; the ven-
tricle doesn’t beat, and there are blood flow defects.
Downregulation of miRNA-143 disrupts ventricular myo-
cardial and endocardial architectures, probably through the
repression of aldh1a2 and rxrab, which encode the retinoid
X receptor alpha b, and then through an aberrant activation
of RA signaling. This study demonstrates that mechanical
forces regulate the expression of miRNA-143 to set up a
gradient of RA signaling in the developing heart. Under-
standing how mechanical stimuli are converted in
biological responses in the developing heart can be useful
for giving insight into the mechanism of both congenital
and acquired heart disease and then how to prevent or
combat them.
Another study showed that miRNA-143 is required for
heart chamber morphogenesis through a direct repression
of add3 (adducin 3), which encodes an F-actin capping
protein, in myocardial cells [101]. Deacon et al. observed
that downregulation of miRNA-143 inhibits ventricular
cardiomyocyte F-actin remodeling. As a consequence,
cellular growth and elongation are blocked and cause
ventricular collapse and decreased contractility.
We would speculate that the fact that a phenotype is
evident in zebrafish but not in mouse would reside in a
second copy of miRNA-143, which is present in the zeb-
rafish genome but not in the mouse genome. The second
copy of the miRNA-143 is identical to the one located in
the miRNA-143/145 cluster, but it is in a different genomic
region, and its expression could possibly be controlled by a
different transcriptional unit (data not shown). Alterna-
tively, it is conceivable that the cardiac phenotype of the
miRNA-143 KO mouse model has not been characterized
under ischemic conditions, such as I/R [98].
The miRNA 218
MiRNA-218 is a conserved microRNA situated introni-
cally in Slit2 Slit3, genes that encode ligands of Robo
receptors. Fish et al. [102] demonstrated that the Slit/
miRNA-218/robo signaling pathway regulates migration of
heart precursors in the midline, in part modulating Vegf
signaling in the endocardium. The authors observed that
downregulation of miRNA-218 causes a delayed heart field
migration that results in pericardial edema and abnormal
heart looping. The same phenotypes are caused by the
overexpression of robo1. Demonstrating that robo1 is a
direct target of this microRNA, they found that a ligand-
encoded microRNA regulates the expression of its own
receptor. They subsequently also observed that Vegf is a
mediator of heart field migration in zebrafish: its temporal
inhibition leads to delayed heart field fusion. In vivo it
interacts with robo1, which in turn could facilitate the
phosphorylation of Vegfr2 as demonstrated in vitro. This
study provides evidence of a Slit/miRNA-218/Robo/Vegf
feedback regulatory loop that precisely regulates the
migration of heart fields to form the linear heart tube. It has
also been demonstrated in mouse that miRNA-218 regu-
lates vascular patterning by modulation of Slit-Robo
signaling [103], highlighting a conserved role of miRNA-
218 in this pathway.
The miRNA 133
The zebrafish heart is similar to the human heart in many
respects. But unlike the human heart, after injury the zeb-
rafish heart closes wounds rapidly and regenerates cardiac
tissue to fully restored cardiac muscle function [104].
Specific molecular networks have been associated to these
regeneration events [105, 106]. These findings have sug-
gested a potential role of microRNA in the regulation of
heart regeneration and offer hope that this event could also
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be induced in mammals. Yin et al. [79], through a micro-
array analysis of microRNA differentially expressed after
the resection of the ventricle apex of the adult zebrafish
heart, found that miRNA-133 expression correlates with
the regeneration process. In zebrafish, miRNA-133 is
downregulated after apex amputation, but progressively
returns to be expressed to baseline when regeneration is
completed. To study miRNA-133 function in adult heart
regeneration, these authors generated two zebrafish trans-
genic lines through which they modulate miRNA levels in
adult animals during regeneration. For overexpression
studies, they generated a transgenic line containing 250 bp
of genomic sequences flanking the sides of the miRNA-
133a1 precursor sequence downstream of the hsp70 pro-
moter. Adult transgenic animals exposed to a single heat
treatment showed a 1.8 increase of mature miR-133. For
downregulating miRNA-133, the authors created another
transgenic line using an miRNA-133 sponge construct
(encoding EGFP cDNA followed by triplicate perfect
binding sites for miRNA-133) placed downstream of the
hsp70 promoter. They showed that, remarkably, a single
heat shock was sufficient to transiently but efficiently
knock down adult cardiac miRNA-133 expression. Using
these transgenic lines it was possible to discover that
miRNA-133 inhibits myocardium regeneration reducing
cardiomyocyte proliferation. Microarray analyses on miR-
133-overexpressing/downregulated adult zebrafish identified
cell cycle regulators such as monopolar spindle 1 (mps1), an
essential factor for heart regeneration [107], and cytoskele-
tal/structural component proteins such as connexin-43
(cx43), a gene implicated in human cardiomyopathies [108],
as direct targets of miRNA-133. The results of Yin et al. are
also consistent with the elevated cardiomyocyte proliferation
displayed by miR-133a1/a2 double knockout mice [109].
This work highlights the utility of the zebrafish model
for studying the role of microRNAs also in the adult
cardiovascular system in physiopathological contexts.
Although we are still far from the possibility of inducing
heart regeneration mammals, dissecting this process in
zebrafish can provide context for understanding and possibly
enhancing the cardiac regenerative capacity in mammals.
In summary, miRNA-133, a conserved miRNA known
to have a role in cardiac development and disease in
mammals [12], regulates zebrafish heart regeneration [79].
This work further demonstrates the versatility of the zeb-
rafish model for miRNA studies not only during embryonic
development, but also in the adult animal.
Vascular-specific miRNAs
Formation of a functional vasculature during vertebrate
development is essential for embryonic survival. Physio-
logical aspects of the vascular system have been
extensively studied, resulting in its clinical importance.
Thus far studies have shown a high degree of conservation
of the molecular mechanisms that govern zebrafish vas-
cular development as well as in the anatomical structures
that comprise the vascular system in vertebrates. In zeb-
rafish embryos both endothelial cell functions and
angiogenesis are critically regulated by microRNAs
(Fig. 3). Here are some examples of studies conducted by
knockdown or ectopic overexpression of specific micro-
RNAs and their effects on angiogenesis and endothelial
cell behavior.
The miRNA 24
The miRNA-23/27/24 gene cluster is enriched in human
endothelial cells and in highly vascularized tissues such as
the heart. Recently, several reports have demonstrated that
the miRNA-23/24/27 cluster is involved in heart and
Fig. 3 Schematic
representation of zebrafish trunk
vessels showing endothelial
cells (EC, pink), tip cells (red),
and smooth muscle cells (SMC,
blue) of the dorsal aorta (DA),
posterior cardinal vein (PCV),
and intersegmental vessels (Se).
The expression of select
miRNAs is shown, along with
their observed target and
functional roles (see text for
details)
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vascular development and homeostasis in zebrafish [35,
110]. Overexpression of miRNA-24 in zebrafish embryos
resulted in pericardial edema as well as blood accumula-
tion. Studies in transgenic zebrafish that express GFP in
the vasculature showed that miRNA-24 overexpression
impaired intersegmental vessel formation and resulted in
impaired blood transportation [110]. Morpholino-mediated
silencing of the miRNA-24 targets gata2 and pak4 in
zebrafish mimicked the effects of miRNA-24 overexpres-
sion, showing an involvement and potential therapeutic
importance of those targets in angiogenesis [110]. These
recent data also propose miRNA-24 as a suitable target for
therapeutic intervention in cardiovascular diseases [111].
The miRNA 31
Using a TaqMan-based qRT-PCR profiling platform for
signature miRNAs, miRNA-31 showed up as an important
endothelial miRNA [112]. In vivo gain-of-function studies
with zebrafish embryos established that overexpression of
miRNA-31 impaired lymphatic development and reduced
endothelial venous sprouting. Taken together, these find-
ings indicate that miRNA-31 plays a pivotal role in
regulating lineage-specific differentiation within the
developing vasculature of vertebrates.
The miRNA 92
Many microRNAs involved in pathological angiogenesis,
such as tumor angiogenesis, modulate tumor growth by
controlling the production of angiogenic factors and then
neovascularization. The miRNA 17–92 cluster is tran-
scribed as a polycistronic unit and selectively targets anti-
angiogenic proteins [113]. Inside this cluster, miRNA-92a
seems to be important in the control of cardiovascular
system homeostasis in vertebrates. By using antagomir
approaches, Dimmeler’s group determined that miRNA-
92a is highly expressed in endothelial cells and regulates
angiogenic functions of endothelial cells as evidenced by
gain of function and loss of function experiments in vitro
[114]. To demonstrate the conservative role of this micro-
RNA, overexpression of miRNA-92a in zebrafish not only
impairs in vitro angiogenesis but also blocks intersomitic
vessel growth [114]. One of the mechanisms through which
miRNA-92 controls endothelial cell functions seems to be
the direct regulation of integrin subunit a5 (itga5), a cru-
cial regulator of vessel growth and angiogenesis [115].
MiRNA-92a is expressed also in mammal cardiac fibro-
blasts and cardiomyocytes, and antagomir-92a treatment
significantly reduced apoptosis of cardiomyocytes in vivo,
but did not directly affect survival of cardiomyocytes in
cell culture assays in vitro, indicating that antagomir-92a
may influence cardiomyocyte apoptosis via a paracrine
mechanism. Interestingly, it has been observed that ath-
eroprotective flow patterns decrease the level of miRNA-
92a, which in turn increases KLF2 expression to maintain
endothelial homeostasis [116].
The miRNA 126
MiRNA-126 is one of the most evolutionary conserved and
enriched microRNAs in human and mouse endothelial cells
[117, 118] and is also expressed in the zebrafish vascular
tree throughout development [67, 119]. In 2008, different
groups analyzed and reported vascular defects in miRNA-
126-deficient cells, ranging from zebrafish to human and
mice. MiRNA-126 has been clearly shown to be a master
non coding RNA in vascular functions acting as a regulator
of angiogenic integrity and signaling in vitro and in vivo
[119–121] and recently also in heart valve development
[122]. In zebrafish, the downregulation of miRNA-126
induced collapsed blood vessels and cranial hemorrhages
in the developing organism, suggesting its primary role for
maintaining vascular structure during development [119].
Sprouty-related EVH1 domain-containing protein 1
(Spred1) and a regulatory subunit of PI3K, PIK3R2 (also
known as p85b), two direct targets of miRNA-126, seem to
explain these angiogenic defects. MiRNA-126 regulates
Spred1 and PIK3R2, which are negative regulators of
MAPK [123] and PI3K [124] signaling pathways, respec-
tively. As a consequence, miRNA-126 promotes VEGF
and other growth factor signaling in ECs in vivo. As a
matter of fact, miRNA-126 may fine-tune angiogenic
responses by targeting multiple signaling pathways [119,
125]. Remarkably, deletion of miRNA-126 in mice resul-
ted in the same vascular developmental defects observed in
zebrafish, such as delayed angiogenic sprouting, wide-
spread hemorrhaging, and partial embryonic lethality [120,
121], supporting the idea that the zebrafish model can be a
simple and easy tool to discovery miRNA functions in
vertebrates. Recent studies in zebrafish demonstrate for the
first time that miRNA-126 expression and the egfl7 gene
are both under the control of blood flow. Blood flow-
dependent Kruppel-like factor 2a (klf2a) induces expres-
sion of miRNA-126 to modulate Vegf signaling [67].
The miRNA 221
Formation of new vessels in normal and pathological
conditions requires coordination of distinct cell behaviors
between tip and stalk cells [126]. The Vegf and Notch
signaling pathways govern this process. Recently, through
deep sequencing and functional screening in zebrafish, a
new microRNA has been associated to this process [65].
MiRNA-221 has been found to be essential for angiogen-
esis since it is required for tip cell proliferation and
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migration. miRNA-221 promoted tip cell behavior through
repression of two targets: cyclin-dependent kinase inhibitor
1b (cdkn1b) and phosphoinositide-3-kinase regulatory
subunit 1 (pik3r1). Importantly, these results in zebrafish
indicate the central role of miRNA-221 as a regulatory
node through which tip cell migration and proliferation are
controlled during angiogenesis [65, 127]. A main role for
miRNA-221/222 in endothelial therapeutic applications in
humans has also been proposed [128]. In fact, recent work
demonstrate that miRNA-221 is regulated by hyperglyce-
mia in HUVEC cells, and lipid-lowering therapies (LLT)
with atorvastatin increases EPC numbers and decreases
miRNA-221/222 levels in patients with coronary artery
disease [129, 130].
Conclusion
In this review, we pointed out the important role of the
vertebrate Danio rerio, commonly called ‘‘zebrafish,’’ in
helping to understand microRNA functions in heart and
vascular cells not only during development but also in
pathological conditions.
Recent discoveries have demonstrated that the zebrafish
system can be used to study tissue regeneration since adult
zebrafish can effectively regenerate injured hearts submit-
ted to partial surgical amputation of the ventricle area
in vivo. Limited information is currently available about
the molecular mechanisms that regulate this process [131].
In particular, which microRNAs can be involved in this
process remains unclear. Identification of microRNAs
active during the regenerative potential of vertebrate/zeb-
rafish tissue may implicate the discovery of new
therapeutic approaches to supplement or replace conven-
tional pharmacotherapeutic interventions in humans.
Recently, the possibility has also been suggested that
microRNAs can be transported between cardiovascular
tissues and regulate athero-vascular protection by an
extracellular-vesicle-mediated mechanism [132, 133].
Demonstration of a role for circulating microRNAs could
be validated in the zebrafish model system by microin-
jecting exogenous microRNA-containing liposomes in the
blood flow of developing embryos to detect a functional
role for mature microRNAs in cardiovascular tissues.
Interestingly, the zebrafish model can be used to per-
form pharmaceutical high-throughput modifier screens.
The use of small RNA molecules such as microRNA
products through such screens will serve as ideal entry
points for novel drug development in the treatment of many
vascular dysfunctions. Also, for miRNA-based therapeutic
strategies the zebrafish model will come in handy. Anti-
sense oligonucleotide approaches for inhibiting miRNA
function and gain-of-function technologies for replacement
of miRNAs are currently being explored as tools for
uncovering miRNA biology and as potential therapeutic
agents. We think that in the near future significant progress
in understanding miRNA biology will be derived from the
zebrafish system, and this model will help to advance the
technology for therapeutic modulation of miRNA activity
in cardiovascular diseases.
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